Hemoglobin-bound heme iron(II) (Hb-Fe2+)

Hemoglobin-bound heme iron(II) represents the functional ferrous state of the iron-protoporphyrin IX complex within the hemoglobin protein, which is essential for the transport of molecular oxygen from the lungs to the tissues (StatPearls: Hemoglobin Physiology). This metallic center coordinates with oxygen in a reversible manner, transitioning between the deoxygenated (T-state) and oxygenated (R-state) forms through allosteric regulation (UniProt: HBB). In clinical practice, this site is a major focus for treating sickle cell disease, where drugs like Voxelotor bind to the hemoglobin tetramer to increase its affinity for oxygen, thereby maintaining the iron in its oxygenated state and preventing the polymerization of sickle hemoglobin (FDA: Oxbryta). Additionally, the redox balance of this iron is critical; the oxidation of Fe2+ to Fe3+ creates methemoglobin, which is incapable of binding oxygen and leads to functional anemia (StatPearls: Methemoglobinemia). Therapeutic agents like methylene blue are used to reduce the iron back to the ferrous state, restoring normal gas exchange. The iron center also serves as a binding site for other ligands, including carbon monoxide and nitric oxide, which can have both toxicological and therapeutic implications depending on the context of exposure (PubChem: Heme).

Other names

Ferrous hemeIron(II) protoporphyrin IXHeme bDeoxyhemoglobin ironOxyhemoglobin ironHb-Fe(II)

The mechanism of action for drugs targeting hemoglobin-bound heme iron(II) involves either the allosteric stabilization of the oxygenated (R-state) conformation to prevent pathological polymerization of hemoglobin S (e.g., Voxelotor) (FDA: Oxbryta), the direct competitive coordination of therapeutic gases to the iron center to modulate vascular tone (e.g., Nitric oxide) (StatPearls: Hemoglobin Physiology), or the chemical reduction of the inactive ferric (Fe3+) state back to the functional ferrous (Fe2+) state to restore oxygen transport capacity (e.g., Methylene blue) (StatPearls: Methemoglobinemia).